A new oral anticoagulant, dabigatran etexilate (DE, a prodrug of direct thrombin inhibitor (DTI) dabigatran), has been used clinically to prevent thrombosis. The assessment of dabigatran efficiency is ...
Critically ill patients are at an increased risk of venous thromboembolism, and routine pharmacological thromboprophylaxis forms a part of the standard of care in this patient cohort. In this context, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results